Dermatology
News
Secukinumab Tames Hand, Foot Psoriasis
Major Finding: Fifty-four percent of patients with moderate to severe hand and foot psoriasis were rated clear or had only minimal disease at...
Conference Coverage
Evidence Backs Some Drugs for Hidradenitis Suppurativa
Conference Coverage
Tacrolimus 0.03% Favored for Atopic Blepharoconjunctivitis
Major Finding: The conjunctivitis response rates were 80%, 55%, and 50% with tacrolimus, pimecrolimus, and topical steroids, respectively.
Conference Coverage
Surgery for Hidradenitis Suppurativa: Results Mostly Suboptimal
Major Finding: Fifty-one percent of patients who underwent surgery for hidradenitis suppurativa experienced one or more indicators of unmet needs...
Conference Coverage
Evidence Links Hidradenitis Suppurativa to Metabolic Syndrome
Major Finding: In three European studies, patients with hidradenitis suppurativa had an adjusted 2.35-, 5.8-, and 4.46-fold prevalence of...
Conference Coverage
High-Dose Finasteride Halts Hair Loss in Women
Major Finding: Of premenopausal women with androgenetic alopecia, 58% reported major improvement in response to oral finasteride at 5 mg/day, and...
Conference Coverage
Novel Rosacea Gel Scores in Phase III Trial
Major Finding: Thirty minutes after the first application on study day 1, 28% of patients in the active treatment arm showed at least a 1-grade...
News
Vein Sealed With Superglue-Based Implant
Major Finding: Of 38 patients with an incompetent great saphenous vein who were treated with a proprietary formulation of cyanoacrylate adhesive,...
Conference Coverage
Psoriasis Flares Rapidly Postpartum
News
Tanning Bed Risks Not Communicated to 73% of Germans
Major Finding: The overall prevalence of tanning bed use was nearly 40%, with most users being aged 18-25 years (mean prevalence, 21.4%).Data...
News
Psoriasis Plus Diabetes Equals Heightened Vascular Risk
Major Finding: Patients with diabetes and psoriasis had 5-year risks of new-onset microvascular and macrovascular diabetic complications that were...